102 related articles for article (PubMed ID: 19538495)
1. Dissolution in nasal fluid, retention and anti-inflammatory activity of fluticasone furoate in human nasal tissue ex vivo.
Baumann D; Bachert C; Högger P
Clin Exp Allergy; 2009 Oct; 39(10):1540-50. PubMed ID: 19538495
[TBL] [Abstract][Full Text] [Related]
2. Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate.
Valotis A; Högger P
Respir Res; 2007 Jul; 8(1):54. PubMed ID: 17650349
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis.
Stokes M; Amorosi SL; Thompson D; Dupclay L; Garcia J; Georges G
Otolaryngol Head Neck Surg; 2004 Sep; 131(3):225-31. PubMed ID: 15365540
[TBL] [Abstract][Full Text] [Related]
4. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
Mandl M; Nolop K; Lutsky BN
Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
[TBL] [Abstract][Full Text] [Related]
5. Deposition of intranasal glucocorticoids--preliminary study.
Rapiejko P; Sosnowski TR; Sova J; Jurkiewicz D
Otolaryngol Pol; 2015; 69(6):30-8. PubMed ID: 26860605
[TBL] [Abstract][Full Text] [Related]
6. A review of the use of fluticasone furoate since its launch.
Villa E; Magnoni MS; Micheli D; Canonica GW
Expert Opin Pharmacother; 2011 Sep; 12(13):2107-17. PubMed ID: 21797803
[TBL] [Abstract][Full Text] [Related]
7. GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone.
Hamilos DL; Leung DY; Muro S; Kahn AM; Hamilos SS; Thawley SE; Hamid QA
J Allergy Clin Immunol; 2001 Jul; 108(1):59-68. PubMed ID: 11447383
[TBL] [Abstract][Full Text] [Related]
8. Fluticasone furoate is more effective than mometasone furoate in restoring tobacco smoke inhibited SOCS-3 expression in airway epithelial cells.
Nasreen N; Gonzalves L; Peruvemba S; Mohammed KA
Int Immunopharmacol; 2014 Mar; 19(1):153-60. PubMed ID: 24434372
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
Ratner PH; van Bavel JH; Martin BG; Hampel FC; Howland WC; Rogenes PR; Westlund RE; Bowers BW; Cook CK
J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel model for comparative evaluation of intranasal pharmacokinetics and effects of anti-allergic nasal sprays.
Baumann D; Bachert C; Högger P
Eur J Pharm Biopharm; 2012 Jan; 80(1):156-63. PubMed ID: 21945271
[TBL] [Abstract][Full Text] [Related]
12. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.
Fokkens WJ; Jogi R; Reinartz S; Sidorenko I; Sitkauskiene B; van Oene C; Faris MA; Ellsworth A; Caldwell MF
Allergy; 2007 Sep; 62(9):1078-84. PubMed ID: 17686111
[TBL] [Abstract][Full Text] [Related]
13. Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study.
Tas A; Yagiz R; Yalcin O; Uzun C; Huseyinova G; Adali MK; Karasalihoglu AR
Otolaryngol Head Neck Surg; 2005 Apr; 132(4):608-12. PubMed ID: 15806055
[TBL] [Abstract][Full Text] [Related]
14. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
Gradman J; Caldwell MF; Wolthers OD
Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
[TBL] [Abstract][Full Text] [Related]
15. Suppression of cytokine release by fluticasone furoate vs. mometasone furoate in human nasal tissue ex-vivo.
Zhang N; Van Crombruggen K; Holtappels G; Lan F; Katotomichelakis M; Zhang L; Högger P; Bachert C
PLoS One; 2014; 9(4):e93754. PubMed ID: 24710117
[TBL] [Abstract][Full Text] [Related]
16. A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis.
Andersson M; Berglund R; Greiff L; Hammarlund A; Hedbys L; Malcus I; Nilsson P; Olsson P; Sjölin IL; Synnerstad B
Rhinology; 1995 Mar; 33(1):18-21. PubMed ID: 7784789
[TBL] [Abstract][Full Text] [Related]
17. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids.
Smith CL; Kreutner W
Arzneimittelforschung; 1998 Sep; 48(9):956-60. PubMed ID: 9793625
[TBL] [Abstract][Full Text] [Related]
18. The effects of fluticasone propionate on nasal epithelial potential difference.
Graham SM; Scott SN; Launspach J; Zabner J
Am J Rhinol; 2002; 16(3):145-9. PubMed ID: 12141771
[TBL] [Abstract][Full Text] [Related]
19. [Fluticasone propionate reduced the production of GM-CSF, IL-6 and IL-8 generated from cultured nasal epithelial cells].
Ohnishi M; Takizawa R; Ohkubo K; Yokosima K; Okuda M; Yagi T
Arerugi; 1994 Mar; 43(3):441-7. PubMed ID: 8198453
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.
Rosenblut A; Bardin PG; Muller B; Faris MA; Wu WW; Caldwell MF; Fokkens WJ
Allergy; 2007 Sep; 62(9):1071-7. PubMed ID: 17686110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
